Physician profile
Mary E Geiss
NPI 1508205980
$3,183.74
in general payments reported to CMS, 2019-2025
32 companies · $1,404 in 2025
The $1,404 reported for 2025 was more than what 91% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $208 · 2020: $18.11 · 2021: $90.63 · 2022: $260 · 2023: $431 · 2024: $772 · 2025: $1,404.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,608.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,607.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $677.83 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $218.25 | 2024-2025 | Airsupra, Breztri, Farxiga |
| Glaxosmithkline, LLC. | $194.97 | 2022-2025 | Trelegy Ellipta, Shingrix, Arexvy |
| Pfizer INC. | $194.10 | 2022-2025 | |
| Lilly USA, LLC | $166.80 | 2022-2025 | Jardiance, Zepbound, Mounjaro |
| Novo Nordisk INC | $158.19 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Exact Sciences Corporation | $137.83 | 2023-2025 | Cologuard Collection Kit |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $132.88 | 2025 | Caplyta |
| Otsuka America Pharmaceutical, INC. | $117.38 | 2025 | Rexulti |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $116.32 | 2022-2025 | Xifaxan, Trulance |
| Corcept Therapeutics | $107.62 | 2025 | Korlym |
| Amgen INC. | $94.70 | 2019-2025 | Repatha, Otezla, Evenity |
| Janssen Pharmaceuticals, INC | $93.01 | 2019-2024 | Spravato |
| Merck Sharp & Dohme LLC | $78.97 | 2019-2024 | Gardasil 9, Gardasil, Capvaxive |
| Takeda Pharmaceuticals U.S.A., INC. | $78.28 | 2022-2025 | Eohilia, Trintellix |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Phathom Pharmaceuticals, INC. | $58.74 | 2024-2025 | Voquezna |
| Shield Therapeutics INC | $58.28 | 2023-2025 | Accrufer |
| Kyowa Kirin, INC. | $56.85 | 2024-2025 | Crysvita |
| Astellas Pharma US INC | $51.59 | 2024-2025 | Veozah |
| Insulet Corporation | $49.54 | 2024-2025 | Omnipod |
| Gilead Sciences, INC. | $46.64 | 2025 | |
| Biogen, INC. | $45.79 | 2025 | Zurzuvae |
| Boehringer Ingelheim Pharmaceuticals, INC. | $44.77 | 2019-2024 | Spiriva Respimat, Jardiance, Stiolto Respimat |
| Ferring Pharmaceuticals INC. | $41.98 | 2021 | |
| Tactile Systems Technology INC | $33.00 | 2025 | Flexitouch Plus, Nimbl |
| Grifols USA, LLC | $28.08 | 2019 | |
| Amarin Pharma, INC. | $25.81 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $17.37 | 2023 | |
| Corium, LLC | $16.14 | 2023 | Azstarys |
| Allergan, INC. | $15.55 | 2019 | |
| Lundbeck LLC | $14.56 | 2024 | Rexulti |
| Supernus Pharmaceuticals, INC. | $11.92 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mary Geiss listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.